BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6220190)

  • 41. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Etidronate disodium in the treatment of Paget's disease of bone.
    Krane SM
    Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current diagnosis and management of Paget's disease of bone.
    Hsu TH
    Md State Med J; 1977 May; 26(5):48-50. PubMed ID: 140278
    [No Abstract]   [Full Text] [Related]  

  • 46. Pathophysiology and modern management of Paget's disease.
    Ryan WG
    Compr Ther; 1983 Sep; 9(9):64-9. PubMed ID: 6226475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
    Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
    Adami S; Guarrera G; Salvagno G; Spiazzi G; Marini G; Rosini S; Lo Cascio V
    Metab Bone Dis Relat Res; 1984; 5(6):265-7. PubMed ID: 6238218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
    Alexandre C; Trillet M; Meunier P; Fischer C
    Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Paget disease of the skeleton. Internal medicine aspects].
    Ziegler R; Baldauf G
    Radiologe; 1984 Sep; 24(9):401-7. PubMed ID: 6238341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of disodium etidronate on Paget's disease of bone.
    Muir HG; Schabort I; Hough FS
    S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of Paget's disease].
    Agrest A
    Medicina (B Aires); 1979; 39(2):275-6. PubMed ID: 159393
    [No Abstract]   [Full Text] [Related]  

  • 55. Diphosphonate therapy of paget's disease of bone.
    Canfield R; Rosner W; Skinner J; McWhorter J; Resnick L; Feldman F; Kammerman S; Ryan K; Kunigonis M; Bohne W
    J Clin Endocrinol Metab; 1977 Jan; 44(1):96-106. PubMed ID: 401827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of Paget's disease of bone].
    Mimura K
    Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):751-61. PubMed ID: 3936894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
    Altman RD
    Am J Med; 1985 Nov; 79(5):583-90. PubMed ID: 3933343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paget's disease of bone: recent advances in therapy.
    Canalis EM; Mundy GR; Raisz LG
    Conn Med; 1977 Feb; 41(2):79-83. PubMed ID: 138526
    [No Abstract]   [Full Text] [Related]  

  • 60. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.